An Event-driven Trial for Oral Treprostinil. Progress but Not the Holy Grail
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Respiratory and Critical Care Medicine"
DOI: 10.1164/rccm.201912-2431ed
Abstract: Finally, this study suffers from underpowering, as it includes just 102 samples, less than half of which are the preinvasive AIS/MIA lesions of interest. Atypical alveolar hyperplasia, a presumed precursor of AIS, was not studied.… read more here.
Keywords: oral treprostinil; driven trial; treprostinil progress; trial oral ... See more keywords